Organization · Venture Capital
Unicorn Capital Partners
Unicorn Capital Partners is a Moscow-based venture capital firm specializing in life sciences and biotechnology investments. They focus on early-stage to mature assets in pharmaceuticals and medical devices, providing both capital and consulting services.
Overview
What Unicorn Capital Partners does
What Unicorn Capital Partners is
Unicorn Capital Partners is a Moscow-based venture capital firm specializing in life sciences and biotechnology investments. They focus on early-stage to mature assets in pharmaceuticals and medical devices, providing both capital and consulting services.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- April 24, 2026
Official channels
Find Unicorn Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Unicorn Capital Partners as a funder
Investment thesis
Unicorn Capital Partners invests in biotech, pharma, and medtech companies addressing unmet medical needs in Russia and globally.
Focus narrative
The firm engages in venture investments across early-stage to mature commercial assets in pharmaceuticals and medical devices. Unicorn Capital Partners also provides scientific-technical and management support to enhance the success of innovative projects in the life sciences sector.
Value beyond capital
Unicorn Capital Partners offers scientific-technical and management support for innovative projects, leveraging their expertise in the biotechnology sector to enhance portfolio company success.
Focus and fit
- Stages
- Friends and Family · Angel · Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- Global · Europe · Asia
Availability
- Currently deploying
- Yes
Capability profile
Unicorn Capital Partners as a publisher
Editorial focus
Unicorn Capital Partners specializes in venture investments and consulting services within the biotechnology sector. Their focus includes early-stage to mature commercial assets in pharmaceuticals and medical devices, considering scientific, market, regulatory, corporate, and financial factors. They also provide scientific-technical and management support for innovative projects.
Audience value
Unicorn Capital Partners offers expertise in biotechnology investments, aiming to support innovative projects that address unmet medical needs in Russia and globally.
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors
- Regions
- Global · Europe · Asia
Common questions
What to know about Unicorn Capital Partners
Upseed classifies Unicorn Capital Partners under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.